Together, these results support a favorable safety profile for mCD155 CAR-T cells and suggest that even in a setting of relatively broad CD155 expression, low-affinity CAR-T cells derived from the G06 clone do not induce marked on-target, off-tumor toxicity or neurotoxicity. This evidence concerns the gene PVR and neoplasm.